BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29786509)

  • 1. [Targeted screening for pre-eclampsia in the first trimester of pregnancy at Toulouse University Hospital].
    Genoux A; Guerby P; Morin M; Perret B; Vayssière C; Hamdi SM
    Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):111-118. PubMed ID: 29786509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for the prospective validation study: 'Screening programme for pre-eclampsia' (SPREE).
    Tan MY; Koutoulas L; Wright D; Nicolaides KH; Poon LCY
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):175-179. PubMed ID: 28295773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
    Tan MY; Wright D; Syngelaki A; Akolekar R; Cicero S; Janga D; Singh M; Greco E; Wright A; Maclagan K; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):743-750. PubMed ID: 29536574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of first trimester biochemical markers and mean arterial pressure in prediction of early-onset pre-eclampsia.
    Nevalainen J; Korpimaki T; Kouru H; Sairanen M; Ryynanen M
    Metabolism; 2017 Oct; 75():6-15. PubMed ID: 28964327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations.
    O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; de Alvarado M; Carbone IF; Dutemeyer V; Fiolna M; Frick A; Karagiotis N; Mastrodima S; de Paco Matallana C; Papaioannou G; Pazos A; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):756-760. PubMed ID: 28295782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia.
    Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM
    Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Fetal Medicine Foundation algorithm for prediction of pre-eclampsia in the first trimester in an unselected Brazilian population.
    Lobo GAR; Nowak PM; Panigassi AP; Lima AIF; Araujo Júnior E; Nardozza LMM; Pares DBS
    J Matern Fetal Neonatal Med; 2019 Jan; 32(2):286-292. PubMed ID: 28889785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model.
    Agarwal R; Chaudhary S; Kar R; Radhakrishnan G; Tandon A
    J Obstet Gynaecol; 2017 Oct; 37(7):877-882. PubMed ID: 28569565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary.
    Orosz L; Orosz G; Veress L; Dosa D; Orosz L; Arany I; Fabian A; Medve L; Pap K; Karanyi Z; Toth Z; Poka R; Than NG; Torok O
    J Biotechnol; 2019 Jul; 300():11-19. PubMed ID: 31055145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm.
    Poon LC; Rolnik DL; Tan MY; Delgado JL; Tsokaki T; Akolekar R; Singh M; Andrade W; Efeturk T; Jani JC; Plasencia W; Papaioannou G; Blazquez AR; Carbone IF; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):738-742. PubMed ID: 29380918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy.
    Park FJ; Leung CH; Poon LC; Williams PF; Rothwell SJ; Hyett JA
    Aust N Z J Obstet Gynaecol; 2013 Dec; 53(6):532-9. PubMed ID: 23919594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study.
    Guy GP; Leslie K; Diaz Gomez D; Forenc K; Buck E; Khalil A; Thilaganathan B
    BJOG; 2021 Jan; 128(2):149-156. PubMed ID: 32613730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MoM cutoffs for variables, an important tool for multivariate analysis and accurate interpretation of preeclampsia risk in high-risk pregnancy at 11-13
    Verma J; Thomas DC; Jhingan G; Puri RD; Verma IC
    Hypertens Pregnancy; 2016 Nov; 35(4):548-558. PubMed ID: 27599037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia.
    Ortved D; Hawkins TL; Johnson JA; Hyett J; Metcalfe A
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):239-244. PubMed ID: 29700870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASPRE trial: performance of screening for preterm pre-eclampsia.
    Rolnik DL; Wright D; Poon LCY; Syngelaki A; O'Gorman N; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Papaioannou G; Tenenbaum-Gavish K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):492-495. PubMed ID: 28741785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia.
    Di Lorenzo G; Ceccarello M; Cecotti V; Ronfani L; Monasta L; Vecchi Brumatti L; Montico M; D'Ottavio G
    Placenta; 2012 Jun; 33(6):495-501. PubMed ID: 22459245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
    Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First trimester combined screening for preeclampsia and small for gestational age - a single centre experience and validation of the FMF screening algorithm.
    Mosimann B; Pfiffner C; Amylidi-Mohr S; Risch L; Surbek D; Raio L
    Swiss Med Wkly; 2017; 147():w14498. PubMed ID: 28871576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of Timing First-Trimester Placental Growth Factor and Use of Serial First-Trimester Placental Growth Factor Measurements in Screening for Preeclampsia.
    Mosimann B; Amylidi-Mohr S; Höland K; Surbek D; Risch L; Raio L
    Fetal Diagn Ther; 2017; 42(2):111-116. PubMed ID: 28199996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
    Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.